RSSCategory: Pharmaceuticals

Biotech companies to help with cancer research

March 18, 2019

Biotechnological innovations are the latest addition to the healthcare market with new therapies and drugs to treat cancer more effectively at a reduced cost, although the most common therapies remain immunotherapy, chemotherapy, and radiation therapy. Cancer is the leading cause of death globally – Allied Market Research data from 2017-2023 has estimated the global cancer […]

Continue Reading

New TB vaccine tested on mice shows promise

March 11, 2019

Tuberculosis is a disease caused by the Mycobacterium tuberculosis (Mtb) bacteria, and is the world’s leading killer due to infection according to the WHO. The BCG (bacille-Calmette-Guerin) vaccine – delivered by an intramuscular injection in the upper arm – is made to use against Mtb infections; some 70-80% effective against more severe forms such as […]

Continue Reading

Jamaica receives medical support from India in new agreement

February 22, 2019

India’s pharmaceutical capabilities are reaching new heights – the country is likely to be amongst the highest ranking global markets in value terms by 2020. Indian High Commissioner to Jamaica, His Excellency Sevala Naik said that India has been recognised globally for producing quality medicines at affordable prices. In line with this, a memorandum of […]

Continue Reading

New leukemia drug is more effective and easier to use

January 14, 2019

A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL). The drug, ibrutinib, attacks cancer cells without damaging normal cells, thus causing fewer side effects. The drug is taken as a pill once […]

Continue Reading

Cheap common drugs may aid mental illness

January 11, 2019

Cheap and widely used drugs for diabetes and heart health have potential for treating severe mental illness, a study hints. It showed the number of times patients needed hospital treatment fell by up to a fifth when they took the drugs. The researchers at University College London say their findings have “enormous potential”. But they, […]

Continue Reading

Diabetic drug can help with heart problem

December 21, 2018

Scientists have discovered that a drug commonly used to treat type 2 diabetes could also help repair heart failure. Close to half of all heart failure patients have HFpEF, which stiffens the left ventricle of the heart and reduces its ability to fill with blood. In turn, that leads to a lack of blood flow […]

Continue Reading

Rising insulin prices will restrict access to half the world by 2030

November 28, 2018

By 2030, about half of the estimated 79 million adults around the globe who have type 2 diabetes won’t have access to insulin. A study published in The Lancet Diabetes & Endocrinology talked about the price and diminishing supply of the drug that helps people with types 1 and 2 diabetes fight off amputation, blindness, […]

Continue Reading

New shingles vaccine proves effective at curbing the infection

October 30, 2018

A new shingles vaccine has proven to be more successful in the prevention of the infection. The Shingrix vaccine was compared to the older vaccine Zostavax, and reviewed by more than 2 million patients above the age 50. Researchers in Toronto found the newer germ-specific vaccine, was 85% more effective in reducing shingles, also known […]

Continue Reading

Combination treatment may extend late-stage breast cancer survival

October 23, 2018

A recent trial proposes combining a specific drug with hormone therapy to extend the survival of some women with advanced breast cancer. The study showed that women who received palbociclib and hormone therapy lived up to 10 months longer than those given hormone treatment alone. It also delayed the time at which women needed to […]

Continue Reading

Scientists in Philadelphia develop promising vaccine against Ebola

October 12, 2018

Scientists at The Wistar Institute Vaccine and Immunotherapy Centers have created a synthetic DNA vaccine that is showing immediate and long-term encouraging results against the Ebola virus in preclinical animal research. The vaccine targets a virus surface protein called glycoprotein, according the findings published in the Journal of Infectious Diseases. First appearing in 1976, The […]

Continue Reading